lobbying_activities: 2261022

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2261022	f98f50c5-51a1-42bd-953a-884e653ef4be	Q1	ALAN REUTHER	400618875	UAW RETIREE MEDICAL BENEFITS TRUST	2019	first_quarter	HCR	Implementation, Repeal and Replacement, and Improvement of ACA; Changes in Medicare Benefits and Financing; CMS initiatives on Part B and Part D drug prices; Insulin prices; measures to limit drug prices; drug price negotiation initiatives; insurance market stabilization legislation; reinsurance programs; Medicaid work requirements and other Medicaid changes; Medicare buy-in legislation; Medicare for All legislation; Medicare X legislation; surprise medical bills; CREATES Act; pay-for-delay agreements; 2020 Call Letter; drug rebates; drug importation	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	18000		0	0	2019-04-01T15:04:37.917000-04:00